title: Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.
abstract: Pulmonary hypertension provokes right heart failure and arrhythmias. Better understanding of the mechanisms underlying these arrhythmias is needed to facilitate new therapeutic approaches for the hypertensive, failing right ventricle (RV). The aim of our study was to identify the mechanisms generating arrhythmias in a model of RV failure induced by pulmonary hypertension. Rats were injected with monocrotaline to induce either RV hypertrophy or failure or with saline (control). ECGs were measured in conscious, unrestrained animals by telemetry. In isolated hearts, electrical activity was measured by optical mapping and myofiber orientation by diffusion tensor-MRI. Sarcoplasmic reticular Ca(2+) handling was studied in single myocytes. Compared with control animals, the T-wave of the ECG was prolonged and in three of seven heart failure animals, prominent T-wave alternans occurred. Discordant action potential (AP) alternans occurred in isolated failing hearts and Ca(2+) transient alternans in failing myocytes. In failing hearts, AP duration and dispersion were increased; conduction velocity and AP restitution were steeper. The latter was intrinsic to failing single myocytes. Failing hearts had greater fiber angle disarray; this correlated with AP duration. Failing myocytes had reduced sarco(endo)plasmic reticular Ca(2+)-ATPase activity, increased sarcoplasmic reticular Ca(2+)-release fraction, and increased Ca(2+) spark leak. In hypertrophied hearts and myocytes, dysfunctional adaptation had begun, but alternans did not develop. We conclude that increased electrical and structural heterogeneity and dysfunctional sarcoplasmic reticular Ca(2+) handling increased the probability of alternans, a proarrhythmic predictor of sudden cardiac death. These mechanisms are potential therapeutic targets for the correction of arrhythmias in hypertensive, failing RVs.
authors.affiliation: Institute of Membrane and Systems Biology, University of Leeds, United Kingdom.
authors.forename: David
authors.initials: D
authors.lastname: Benoist
authors.forename: Rachel
authors.initials: R
authors.lastname: Stones
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Drinkhill
authors.forename: Alan P
authors.initials: AP
authors.lastname: Benson
authors.forename: Zhaokang
authors.initials: Z
authors.lastname: Yang
authors.forename: Cecile
authors.initials: C
authors.lastname: Cassan
authors.forename: Stephen H
authors.initials: SH
authors.lastname: Gilbert
authors.forename: David A
authors.initials: DA
authors.lastname: Saint
authors.forename: Olivier
authors.initials: O
authors.lastname: Cazorla
authors.forename: Derek S
authors.initials: DS
authors.lastname: Steele
authors.forename: Olivier
authors.initials: O
authors.lastname: Bernus
authors.forename: Ed
authors.initials: E
authors.lastname: White
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000503:physiopathology*; D002118:Calcium / Q000378:metabolism; D000252:Calcium-Transporting ATPases / Q000378:metabolism; D004562:Electrocardiography; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology*; D006976:Hypertension, Pulmonary / Q000150:complications*; D008297:Male; D023421:Models, Animal; D032383:Myocytes, Cardiac / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D012519:Sarcoplasmic Reticulum / Q000378:metabolism; D018497:Ventricular Dysfunction, Right / Q000503:physiopathology*
chemical_list: D000252:Calcium-Transporting ATPases; D002118:Calcium